Beijing Science Sun Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Science Sun Pharmaceutical Co Ltd with three other
companies in this sector in China:
Hutchison China Meditech Limited
sales of 1.42 billion Chinese Renmimbi [US$202.92 million]
of which 62%
was Is Operating - Prescription Drugs PRC),
Shanghai Kaibao Pharmaceutical Company Limited
(1.50 billion Chinese Renmimbi [US$214.81 million]
of which 100%
was Industrial), and
Yipinhong Pharmaceutical Co Ltd
(1.43 billion Chinese Renmimbi [US$204.63 million]
of which 67%
was Pharmaceutical Manufacturing).
Beijing Science Sun Pharmaceutical Co Ltd reported sales of 1.43 billion Chinese Renmimbi (US$204.37 million)
December of 2018.
increase of 90.4%
versus 2017, when the company's sales were 749.99 million Chinese Renmimbi.
Sales at Beijing Science Sun Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 197%).